Clinical trials are testing rapamycin for Long COVID and ME (Wade)
- Condition
- Long COVID
- At worst
- Very severe (bedbound, unable to do basic care)
- Ill for
- Not stated
- Published
- Jul 2025
Summary
Wade, a 32-year-old in Nashville who was nearly bedbound with Long COVID, took rapamycin obtained through Healthspan, starting his first dose in March 2025. After an initial negative reaction he reported feeling great in a way he had not for months, able to climb stairs multiple times despite having been largely immobile beforehand. He stopped the drug after the third week of treatment due to side effects including allergies and mouth sores, and the article does not say whether his improvement continued or faded once he discontinued it.
What they credit
Credits Other prescription drugs, Rapamycin / sirolimus.
Similar stories
-
Clinical trials are testing rapamycin for Long COVID and ME (Kelly)
Kelly, a 40-year-old in New York City who was sometimes bed-bound with Long COVID and ME, took rapamycin obtained through AgelessRx starting in November 2024. Within about a week she reported some improvement in her symptoms, though she described the overall…
-
Treatments. Yes, they do exist.
In this follow-up post, Encephalogirl (Michelle) lists an expanded regimen: low-dose naltrexone, low-dose Abilify, guanfacine, about nine months of tenofovir as part of a planned minimum one-year antiviral course, six weeks of low-dose rapamycin at 1mg once…
-
Martin's Paradoxical Temporary ME/CFS Remission Story
Martin became ill after EBV reactivation, Lyme disease and food poisoning, and was bedbound for the last three of his ten years of illness with severe post-exertional malaise. Lyrica, benzodiazepines, tianeptine, quetiapine, rapamycin and methylprednisolone…
-
Rapamycin / Sirolimus for ME / CFS and Central Sensitization
Alivenotkicking, on sirolimus since November 2023 at 1mg building to 3mg weekly, says he does feel more active and less easily fatigable. He immediately qualifies it: he is also on low-dose naltrexone which has definitely helped a lot, so it is hard to say,…